Perritt Capital Management’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,000
| Closed | -$88.8K | – | 305 |
|
|
2024
Q2 | $88.8K | Hold |
12,000
| – | – | 0.05% | 201 |
|
|
2024
Q1 | $94K | Hold |
12,000
| – | – | 0.05% | 196 |
|
|
2023
Q4 | $61K | Hold |
12,000
| – | – | 0.03% | 209 |
|
|
2023
Q3 | $71K | Hold |
12,000
| – | – | 0.04% | 199 |
|
|
2023
Q2 | $89K | Hold |
12,000
| – | – | 0.05% | 203 |
|
|
2023
Q1 | $113K | Hold |
12,000
| – | – | 0.06% | 180 |
|
|
2022
Q4 | $128K | Hold |
12,000
| – | – | 0.07% | 182 |
|
|
2022
Q3 | $89K | Hold |
12,000
| – | – | 0.06% | 177 |
|
|
2022
Q2 | $58K | Buy |
+12,000
| New | +$58K | 0.04% | 179 |
|